Insider moves in IonQ, Hims and Hers, Eli Lilly, and TransMedics reveal bold buys, record sales, and signals worth watching.

Truist raised the firm’s price target on State Street (STT) to $125 from $116 and keeps a Buy rating on the shares as part of a broader research ...

CEO Satya Nadella made a bold statement on the earnings call, saying, "The next big accelerator in the cloud will be quantum, ...